ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,129,403 | -33.9% | 4,398,453 | 0.0% | 0.59% | -31.1% |
Q2 2023 | $45,611,958 | +28.2% | 4,398,453 | 0.0% | 0.86% | +6.8% |
Q1 2023 | $35,583,485 | -48.6% | 4,398,453 | 0.0% | 0.81% | -42.6% |
Q4 2022 | $69,275,635 | +0.1% | 4,398,453 | 0.0% | 1.40% | -4.9% |
Q3 2022 | $69,231,000 | +12.7% | 4,398,453 | 0.0% | 1.48% | -9.8% |
Q2 2022 | $61,403,000 | +95.9% | 4,398,453 | +142.0% | 1.64% | +139.3% |
Q1 2022 | $31,339,000 | -20.9% | 1,817,808 | +17.5% | 0.68% | -83.3% |
Q3 2016 | $39,623,000 | -18.4% | 1,547,152 | -41.1% | 4.09% | -39.2% |
Q2 2016 | $48,534,000 | -2.5% | 2,627,719 | 0.0% | 6.72% | +5.6% |
Q1 2016 | $49,795,000 | -27.9% | 2,627,719 | +2.5% | 6.36% | -6.9% |
Q4 2015 | $69,089,000 | – | 2,564,553 | – | 6.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |